Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

One Simple Fact That Many Apple Inc. (AAPL) Investors Are Forgetting

Page 1 of 2

From an investing standpoint, Apple Inc. (NASDAQ:AAPL) is affected by many different factors over the short run, but as we lengthen the time frame, the stock’s fortunes are undoubtedly tied to earnings growth. Valuation and future product releases are important as well, but investors won’t give the stock much support if its bottom line isn’t up to snuff.

With that being said, there’s quite a bit of improper reporting flying around the blogosphere and we thought it’d be best to set the record straight.

Apple Inc. (AAPL)

According to most armchair analysts, Apple investors should remain wary about next quarter’s (Q1 FY2013) financials, particularly on the earnings front. Officially, Wall Street’s 42 most prominent Apple Inc. (NASDAQ:AAPL) analysts are predicting the company to finish Q1 with earnings of $13.46 per share, down 3% year over year, from Q1 FY2012’s EPS of $13.87.

Unbeknownst to a surprisingly large fraction of the media, though, Apple’s current 13-week quarter is actually seven days shorter than Apple’s fiscal Q1 in 2012. When we adjust Apple Inc. (NASDAQ:AAPL) earnings estimates taking this fact into consideration, we can paint a decidedly different picture of the tech giant’s bottom line.

How exactly can we do this?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!